A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis

Clinical trial NCT06306781 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06306781
Sponsor: RenJi Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Decompensated Cirrhosis

Start date: 2024-03-30
Primary completion: 2026-07-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.